Latest Amines Stories
Study Seeks to Confirm a High Response Rate among Cancer Patients with MET and Axl Genetic Alterations SAN DIEGO, Dec. 23, 2014 /PRNewswire/ -- Mirati Therapeutics, Inc.
Novel Product Being Studied to Treat Neuropathic Pain. NEW YORK, Dec. 22, 2014 /PRNewswire/ -- Relmada Therapeutics, Inc.
Harbor Village Florida comments on US doctors prescribing less painkillers. USA (PRWEB) December 16, 2014 According to HealthDay News in the article
-- Novel irreversible pan-erbB inhibitor is active against patient-derived GBM xenografts overexpressing EGFR, including the disease-driving EGFRvIII mutation MENLO PARK, Calif., Dec.
DUBLIN, Dec. 15, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that it is filing an emergency appeal to the U.S.
In-demand research report “Glyphsoate China Monthly Report 1411” worked out by Guangzhou CCM Information Science & Technology Co.
The documentary “A New Resistance” will tell the story of glyphosate, the
The Oncology Institute of Hope and Innovation is pleased to announce the recent openings of clinical trials this holiday season. Downey, CA (PRWEB) November
- A hairdresser.